Eton Pharmaceuticals (ETON) Revenue (2017 - 2026)
Eton Pharmaceuticals (ETON) revenue from Sep 30, 2017 to Mar 31, 2026. The TTM Eton Pharmaceuticals (ETON) revenue is $87M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Eton Pharmaceuticals (ETON) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +79.93% |
| 3 Years TTM | +52.78% |
| 5 Years TTM | +49.00% |
Annual Revenue change of Eton Pharmaceuticals (ETON)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $24M | -69.64% |
| 2025 | $80M | +104.95% |
| 2024 | $39M | +23.29% |
| 2023 | $32M | +48.89% |
| 2022 | $21M | -2.66% |
| 2021 | $22M | +54475.00% |
| 2020 | $40K | -95.83% |
| 2019 | $960K | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
Comparison Eton Pharmaceuticals (ETON) five years revenue CAGR with competitors
Eton Pharmaceuticals (ETON) five years revenue CAGR is 49.00%.